Suzuki J
Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
ArticleKetamine
Novel pharmacotherapies for opioid use disorder and opioid withdrawal.
ArticlePsychedelics
Views on Psychedelic-Assisted Therapy for Substance Use Disorders from Individuals with Opioid Use Disorder and a History of Injection-Related Infections: A Qualitative Study.
ArticleKetamine
Challenges of enrolling participants with alcohol and opioid use disorders in the emergency department for clinical trials of ketamine: The experience from two randomized controlled trials.
ArticlePsilocybin
Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.
ArticleKetamine
Ketamine in treating opioid use disorder and opioid withdrawal: a scoping review.
ArticlePsychedelics
Survey of Massachusetts peer recovery coaches' attitudes toward the use of psychedelics to treat substance use disorders.
ArticleKetamine
N-methyl-d-aspartate (NMDA) receptor antagonists for treatment of catatonia in adults: Narrative review.
ArticleMDMA